MFS Multimarket Income Trust 

(Public, NYSE:MMT)   Watch this stock   
Find more results for MMT

Address

500 Boylston Stre
Boston, MA 02116
United States - Map
+1-617-9545000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

MFS Multimarket Income Trust discussions

  View all discussions »

Description

MFS Multimarket Income Trust (the Trust) is a closed-end fund and maintains a portfolio that includes investments in investment-grade and high-yield corporate bonds, United States Government securities, and international investment-grade and emerging markets debt securities. The Trust's investment objective is to seek high current income, but may also consider capital appreciation. The Fund’s portfolio includes high yield corporates, high grade corporates, non-United States Government bonds, emerging markets bonds, mortgage-backed securities, United States Treasury securities, commercial mortgage-backed securities, floating rate loans, asset-backed securities, United States Government agencies, residential mortgage-backed securities and collateralized debt obligations. The Trust is managed by Massachusetts Financial Services Company (MFS).

Officers and directors

J. Atwood Ives
Independent Chairman of the Board of Trustees
Age: 73
Bio & Compensation - Reuters
Robert J. Manning
President, Interested Trustee
Age: 45
Bio & Compensation - Reuters
Maria F. Dwyer
President
Age: 50
Bio & Compensation - Reuters
Frank L. Tarantino
Independent Chief Compliance Officer
Age: 65
Bio & Compensation - Reuters
John M. Corcoran
Treasurer
Age: 44
Bio & Compensation - Reuters
Mark N. Polebaum
Secretary, Clerk
Age: 57
Bio & Compensation - Reuters
David L. DiLorenzo
Assistant Treasurer
Age: 41
Bio & Compensation - Reuters
Mark D. Fischer
Assistant Treasurer
Age: 38
Bio & Compensation - Reuters
Ellen Moynihan
Assistant Treasurer
Age: 51
Bio & Compensation - Reuters
James O. Yost
Assistant Treasurer
Age: 49
Bio & Compensation - Reuters